1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Basic facts

(a) Name 1 of the pending invention of this case: 2) the date of claiming a priority of drugs; the date of application (date of submitting translations) / the number of application for such drugs: February 22, 2005; 10-207-70314 on September 5, 2007; 1) the claims (as amended on December 14, 2012) ; 2) the pharmaceutical compounds of this case to increase the gymological compounds; 3) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 1) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the pharmaceutical compounds of this case; 4) the eromatic, alian ether, alian compounds, alkylidine, pyochloro, pyodidididiine.

(ii)an increase in the absorption and bio-treatment of chemical compounds that are not green areas in water centered on ionable cores capable of reaction with ionability, characterized by the selection from the military composed of them (hereinafter referred to as “instant Claim 1”).

2) 【Request 3 Pharmaceutical compound’s chemical compounds are converted from the above pharmaceutical compound to the tetetetetetrain so as to increase the absorption and bio-treatment of the claim. It is a green area on the water with a center capable of ionrating with tetetrain.